Search research articles
Contact Us
Filters
Showing results (91-100 of 471) with videos related to
Page
of 48
Sort By:
Molecular Imaging and Biology
|
December 6, 2005
Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor
David Dingli, Brad J Kemp, Michael K O'Connor, et al.
Mayo Clinic Proceedings
|
August 11, 2018
A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro Amyloidosis
Meera Sridharan, W Edward Highsmith, Paul J Kurtin, et al.
Blood Cancer Journal
|
March 14, 2018
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies
Praful Ravi, Shaji K Kumar, James R Cerhan, et al.
Annals of Hematology
|
January 1, 2022
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey
David Dingli, Joana E Matos, Kerri Lehrhaupt, et al.
Plos Computational Biology
|
November 14, 2007
Genetic progression and the waiting time to cancer
Niko Beerenwinkel, Tibor Antal, David Dingli, et al.
Elife
|
October 16, 2015
Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions
Benjamin Werner, Fabian Beier, Sebastian Hummel, et al.
Journal of Virology
|
August 13, 2010
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry
Matthew K Ennis, Chunling Hu, Shruthi K Naik, et al.
Annals of Hematology
|
May 18, 2023
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
David Dingli, Jaroslaw P Maciejewski, Loree Larratt, et al.
Health and Quality of Life Outcomes
|
August 9, 2024
Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study
Elizabeth A Griffiths, Jae S Min, Wei-Nchih Lee, et al.
AJR. American Journal of Roentgenology
|
July 24, 2010
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
Alan R Penheiter, Troy R Wegman, Kelly L Classic, et al.
Page
of 48
Search research articles
Search
Showing results (91-100 of 471) with videos related to
Sort By:
Page
of 48
Molecular Imaging and Biology
|
December 6, 2005
Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor
David Dingli, Brad J Kemp, Michael K O'Connor, et al.
Mayo Clinic Proceedings
|
August 11, 2018
A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro Amyloidosis
Meera Sridharan, W Edward Highsmith, Paul J Kurtin, et al.
Blood Cancer Journal
|
March 14, 2018
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies
Praful Ravi, Shaji K Kumar, James R Cerhan, et al.
Annals of Hematology
|
January 1, 2022
The burden of illness in patients with paroxysmal nocturnal hemoglobinuria receiving treatment with the C5-inhibitors eculizumab or ravulizumab: results from a US patient survey
David Dingli, Joana E Matos, Kerri Lehrhaupt, et al.
Plos Computational Biology
|
November 14, 2007
Genetic progression and the waiting time to cancer
Niko Beerenwinkel, Tibor Antal, David Dingli, et al.
Elife
|
October 16, 2015
Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions
Benjamin Werner, Fabian Beier, Sebastian Hummel, et al.
Journal of Virology
|
August 13, 2010
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry
Matthew K Ennis, Chunling Hu, Shruthi K Naik, et al.
Annals of Hematology
|
May 18, 2023
Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry
David Dingli, Jaroslaw P Maciejewski, Loree Larratt, et al.
Health and Quality of Life Outcomes
|
August 9, 2024
Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study
Elizabeth A Griffiths, Jae S Min, Wei-Nchih Lee, et al.
AJR. American Journal of Roentgenology
|
July 24, 2010
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
Alan R Penheiter, Troy R Wegman, Kelly L Classic, et al.
Page
of 48